Hong Kong Competition Law Update – Recent enforcement trends and impact on pharmaceutical industry

There were various milestones in the Hong Kong competition enforcement landscape in 2022.  In addition to the Commission’s continuous enforcement efforts against cartel conduct, there has been increased regulatory scrutiny on competition restrictions in vertical relationships.  These include the Commission’s first case against a manufacturer for allegedly imposing a minimum resale price on its distributors and the Commission’s multiple investigations into exclusivity conduct.

In this one-hour seminar, Mr Marcus Pollard and Ms Kathleen Gooi from Linklaters will cover key enforcement trends in the past year, as well as providing you with insights into proceedings in the Competition Tribunal.  We will also discuss how this is relevant to the pharmaceutical industry in Hong Kong and practical tips to ensure full compliance with competition law.

Here is the logistic information:

For enquires and registration, please contact the HKAPI Office by phone or by email. ([email protected])